Closed · SOL-OAA-16-000026 · CFDA 98.001 · Discretionary
HIV Vaccine and Biomedical Prevention Research Project
Federal grant opportunity posted by Agency for International Development, cataloged on Grants.gov.
- $20M-$160M
- Award range
- Closed
- Status
- February 2, 2016
- Close date
- 2
- Expected awards
The verdict
HIV Vaccine and Biomedical Prevention Research Project is a closed discretionary listing from Agency for International Development that offered $20,000,000 -- $160,000,000 across 2 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 753 other opportunities from Agency for International Development.
- $20M-$160M
- award range
- Closed
- application status
- 2
- expected awards
- 98.001
- CFDA program
Archived opportunity record
HIV Vaccine and Biomedical Prevention Researc… is closed (last close February 2, 2016). Check the agency catalog for replacement NOFOs. Agency for International Development still indexes 753 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed February 2, 2016
Est. Total Funding
$180,000,000
Expected Awards
2
Instrument
Cooperative Agreement
Cost Sharing
Required
Description
The HIV/AIDS pandemic continues to be a major global health problem. Despite significantly accelerated implementation of effective prevention and treatment tools to address HIV and AIDS, over 2 million new infections occurred in 2014. Sub-Saharan Africa remains the region most severely affected, bearing the burden of 66% of the HIV positive people in the world. In sub-Saharan Africa, nearly half of the 25.8 million people living with HIV are women. Given the scope of the epidemic, new biomedical tools to prevent HIV are essential. The most promising of these is a safe and effective HIV vaccine that provides durable protection, thus providing a realistic and cost-effective means of reversing HIV on a population level. It is highly unlikely that a global, sustainable solution to the AIDS pandemic will be economically or logistically feasible in the absence of a safe and effective HIV vaccine. Developing and delivering an AIDS vaccine for those most in need will represent a transformational scientific breakthrough and is in lock-step with USAID’s commitment to high-impact development through innovation. Parallel to this noble scientific endeavor supported by USAID since 2001 are concerted efforts to enhance human resources and infrastructure, while creating and nurturing an enabling policy environment and key partnerships in low- and lower middle-income countries that contribute to sustained capacity for science, research and health systems strengthening in the regions most affected by HIV/AIDS.
Catch-all / unrestricted eligibility mark · SOL-OAA-16-000026
Grants.gov marks HIV Vaccine and Biomedical Prevention Researc… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. Applicant cost-sharing is required on the Grants.gov extract. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Agency for International Development book (340 peers, 45% of 754).
- Code 99
- Unrestricted / see official listing
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Lealie M. Perry
More from Agency for International Development
Civil Society Strengthening Program (CSSP)
The USAID BAA for Sustainable Development in Sub-Saharan Africa
Pre-Solicitation Notice - Global Reconciliation Fund - People-to-People (P2P) Peacebuilding
FY 2017 Conflict Mitigation and Reconciliation Programs and Activities (Global Reconciliation Fund)
Pre-Solicitation Notice - Global Reconciliation Fund - People-to-People (P2P) Peacebuilding
What to do next
HIV Vaccine and Biomedical Prevention Researc… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 98.001 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |